Skip to content
Agentic OS
Menu

Intelligence / Healthtech / PMA Approvals / Pramand, LLC

Approvalsdevice change approved (PMA)1 Oct 2026

Pramand, LLC

1 Oct 2026: Device change approved (PMA) · CraniSeal™ Dural Sealant. Recorded in the openFDA device PMA data.

View the source record

Decided
1 Oct 2026
Device
CraniSeal™ Dural Sealant
Specialty
Neurology
Type
Supplement (Normal 180 Day Track No User Fee)
Reason
Postapproval Study Protocol
Reference
P220014 S013
Location
Bedford, MA
What this signal means

A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.

  1. Cardiovascular leads with 53 of 120, then Pathology (15).
  2. 35 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Pramand, LLC

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

More in Neurology

PMA Approvals

See all

Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.